27 July 2023 in ACS Omega
Norfloxacin (NFX), an important antibacterial fluoroquinolone, is a class IV drug according to the biopharmaceutics classification system (BCS) and has low solubility and permeability issues. Such poor physicochemical properties of drug molecules lead to poor delivery and are of serious concern to the pharmaceutical industry for clinical development. We present here a conceptually new approach to deliver NFX, by loading the drug molecule on the porous platform of a biocompatible metal-organic framework (MOF), MIL-100(Fe). The loading of the drug on the MOF leading to NFX@MIL-100(Fe) was characterized by Fourier transform infrared (FTIR), UV-visible spectroscopy, thermogravimetric analyses (TGA), and nitrogen adsorption studies. Controlled experiments resulted in the high loading of the drug molecule (∼20 wt %) along with the desired sustained release. We could further control the release of norfloxacin by coating drug-loaded MIL-100(Fe) with PEG, PEG{NFX@MIL-100(Fe)}. Both drug delivery systems (DDSs), NFX@MIL-100(Fe) and PEG{NFX@MIL-100(Fe)}, were tested for their biocompatibility through toxicity studies. The DDSs are biocompatible and show insignificant cytotoxicity, as revealed by cell viability studies through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
12 September 2022 in Dalton Transactions
In this article, we report the adsorption and catalytic study of the three-dimensional (3D) metal–organic framework (MOF) {Mn2(1,4-bdc)2(DMF)2} (1) (1,4-bdcH2, 1,4-benzene dicarboxylic acid; DMF, N,N-dimethylformamide) together with the synthesis and structure of two new Mn(II)-MOFs {Mn3(Br-bdc)3(DMF)4} (2) and {Mn3(NO2-bdc)3(DMF)4} (3) (Br-bdcH2, 2-bromo-1,4-benzene dicarboxylic acid; NO2-bdcH2, 2-nitro-1,4-benzene dicarboxylic acid) under solvothermal conditions. Compounds 2 and 3 have two-dimensional (2D) extended structures and feature trimeric {Mn3(CO2)6} units that serve as secondary building units for the frameworks. The desolvated compound of 1, denoted as 1′, having potential Mn(II) open metal sites (OMSs) lined in a one-dimensional (1D) Mn-chain interconnected by carboxylate groups, exhibits guest-selective adsorption of solvent vapours wherein the compound shows a stepwise profile with H2O vapour, while a gated isotherm was recorded with MeOH. After realizing the favourable interaction of 1′ with polar solvent molecules, we have used Mn(II) OMSs in 1′ for efficient cyanosilylation reactions of aromatic aldehydes. We have recorded 100% conversion for eight aromatic aldehydes, while several other aldehydes showed appreciable conversion. Notably, the recorded conversions in the case of many substrates are higher than those for many other reported MOF catalysts.
14 May 2024 in Dalton Transactions
We present the use of an amine functionalized 2D aminoclay (AC), in MOF chemistry to prepare MIL-101(Cr)/AC composites, which are exploited as catalysts for efficient conversion of CO 2 into cyclic carbonates at ambient reaction conditions.
10 June 2025 in Dalton Transactions
Benzoxazoles and benzimidazoles are a valuable class of heterocyclic compounds and have numerous therapeutic applications. Herein, we present an efficient and facile synthesis of these compounds using a 3D metal–organic framework (MOF), {Mn2(TPA)2(DMF)2}n, referred to as the Mn-TPA MOF (TPAH2 represents terephthalic acid and DMF denotes N,N-dimethylformamide) as a catalyst. The desolvated MOF, Mn-TPADesolv, with its robust nature and manganese open metal sites (OMSs) serves as an effective heterogeneous catalyst. Mn-TPADesolv efficiently facilitates the synthesis of benzoxazole and benzimidazole derivatives via the reaction of o-aminophenol or o-phenylenediamine with various aromatic aldehydes. We recorded high conversions up to 99.9% in both the reactions under optimised conditions within a short reaction time. The catalytic reactions exhibited a remarkably high turnover number (TON) up to 9990, and a turnover frequency (TOF) up to 333 min−1 for various substrates. Notably, Mn-TPADesolv showed excellent catalytic activity for sterically hindered substrates, such as 1-naphthaldehyde and 9-anthracenecarboxaldehyde, maintaining high TON and TOF values. Furthermore, the recyclability of Mn-TPADesolv revealed that the catalyst could be reused up to 30 cycles with no loss in its structural integrity and catalytic performance. The results obtained in this study demonstrate the excellent catalytic performance of Mn-TPADesolv and emphasize its potential as a scalable, robust, cost-effective catalyst with its broad substrate scope compatibility.